Primary prevention of heart failure: targeting dyslipidaemia and atherosclerotic pathways

Eur J Prev Cardiol. 2024 Aug 22;31(11):1434-1435. doi: 10.1093/eurjpc/zwad044.

Authors

Leah Rethy¹, Sadiya S Khan²

Affiliations

¹ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104.
² Division of Cardiology, Department of Medicine and Preventive Medicine, Feinberg School of Medicine, Northwestern University, 680 N. Lake Shore Drive, 14-002, Chicago, IL 60611.

PMID: 36804691
DOI: 10.1093/eurjpc/zwad044

No abstract available

Publication types

Editorial
Comment

MeSH terms

Atherosclerosis* / etiology
Atherosclerosis* / prevention & control
Dyslipidemias* / complications
Dyslipidemias* / drug therapy
Heart Failure* / prevention & control
Humans
Hypolipidemic Agents / therapeutic use
Primary Prevention* / methods

Substances

Hypolipidemic Agents